Vanguard Global Advisers
INSM icon

Vanguard Global Advisers’s Insmed INSM Stock Holding History

Vanguard Global Advisers’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Sell
108,325
-678
-0.6% -$82.1K 0.01% 610
2026
Q1 		$17.8M Buy
+109,003
New +$16.8M 0.01% 569

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Global Advisers's INSM Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Insmed (INSM) stake by 0.62% in Q2 2026, selling an estimated $82.1K and leaving 108,325 shares worth $11.5M. The position accounts for 0.01% of the portfolio, ranked #610.

Vanguard Global Advisers first reported a position in INSM in Q1 2026 and has held it in 2 quarters since. The position peaked at $17.8M in Q1 2026. 652 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Vanguard Global Advisers held 108,325 shares of Insmed worth $11.5M as of Q2 2026.
  • Vanguard Global Advisers sold 678 Insmed shares in Q2 2026, an estimated $82.1K.
  • Insmed made up 0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #610 holding.
  • Vanguard Global Advisers first reported a position in Insmed in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Insmed position peaked at $17.8M in Q1 2026.
  • 652 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.